Vaxcyte Reports Second Quarter 2020 Financial Results and Provides Business Update
FOSTER CITY, Calif., Aug. 12, 2020 (GLOBE NEWSWIRE) — Vaxcyte, Inc., formerly known as SutroVax, a next-generation vaccine company seeking […]
One Medical Announces Plans to Enter North Carolina and Wisconsin
SAN FRANCISCO, Aug. 12, 2020 (GLOBE NEWSWIRE) — One Medical (NASDAQ: ONEM), a leading national technology-powered primary care organization, today […]
One Medical Introduces One Medical Now Virtual Care
SAN FRANCISCO, Aug. 12, 2020 (GLOBE NEWSWIRE) — One Medical (Nasdaq: ONEM), a leading national digital health and primary care […]
OpGen Reports Second Quarter 2020 Financial Results and Provides Business Update
Total Revenue for Q2 2020 was approximately $1.2 million dollarsBalance sheet strengthened significantly with $6.1 million cash raised in Q2 […]
Guardion Health Sciences Reports Results of Operations for Quarter Ended June 30, 2020
SAN DIEGO, Aug. 12, 2020 (GLOBE NEWSWIRE) — Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI), ), a specialty […]
NGM Bio Provides Business Highlights and Reports Second Quarter 2020 Financial Results
–Sustained progress across clinical development programs spanning liver, retinal and metabolic diseases and cancer––Aldafermin continues to advance toward late-stage [...]
Helius Medical Technologies, Inc. Reports Second Quarter of Fiscal Year 2020 Financial Results
NEWTOWN, Pa., Aug. 12, 2020 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech […]
Cyclacel Pharmaceuticals Reports Second Quarter 2020 Financial Results
BERKELEY HEIGHTS, N.J., Aug. 12, 2020 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), […]
Exela Technologies, Inc. to Host Fireside Chat at the Credit Suisse 3rd Annual FinTech Conference
IRVING, Texas, Aug. 12, 2020 (GLOBE NEWSWIRE) — Exela Technologies, Inc. (“Exela” or the “Company”) (NASDAQ: XELA), a location-agnostic global […]
Salarius Pharmaceuticals Reports Business Highlights and Second Quarter 2020 Financial Results
Company Closes $6.2M Public Offering and Expands Clinical Program to Include Ewing-Related SarcomasConference Call and Live Audio Webcast Scheduled for […]
